PepGen Inc. (NASDAQ:PEPG) shares fell 26% in after-hours trading Wednesday after the U.S. Food and Drug Administration placed a partial clinical hold on the compa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results